Population-level indicators associated with hormonal contraception use: a register-based matched case-control study.
Finland
Hormonal contraception
Inequalities
Municipality
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
07 03 2021
07 03 2021
Historique:
received:
10
09
2020
accepted:
26
02
2021
entrez:
8
3
2021
pubmed:
9
3
2021
medline:
22
5
2021
Statut:
epublish
Résumé
Monitoring factors related to hormonal contraception (HC) use is essential to evaluating public health strategies and promoting access to contraception. We aimed to examine municipal social and health indicators of HC use at the population level, and to identify patterns of inequality across Finnish municipalities. We identified all women (15-49 years) with a redeemed HC prescription in Finland in 2017 (n = 294,445), and a control group of non-users. Municipal social and health indicators at the population level were retrieved from the nationwide Statistics and Indicator Bank. Differences between the groups across 309 municipalities were calculated, and associations of municipal-specific proportions of HC users with municipal-specific indicators were studied using LASSO (Least Absolute Shrinkage and Selection Operator) models. Sociodemographic differences between HC users and non-users were non-homogenous across municipalities. Indicators positively associated with HC use included: larger population and higher proportions of population aged 16-24 years, of household-dwelling units with one person, of persons with higher education, and of divorces among those aged 25-64. Lower HC use was associated with higher proportions of Swedish-speaking population, of those aged 7-15 years, of young people not in education/training, and of household-dwelling units in overcrowded conditions. Lower HC use was also associated with indicators of outpatient and inpatient healthcare, and of municipal finances in welfare and healthcare. Sociodemographic differences in relation to HC use exist across Finnish municipalities. Municipal indicators of social structure, health and welfare, and investment in and use of healthcare services are related to HC use.
Sections du résumé
BACKGROUND
Monitoring factors related to hormonal contraception (HC) use is essential to evaluating public health strategies and promoting access to contraception. We aimed to examine municipal social and health indicators of HC use at the population level, and to identify patterns of inequality across Finnish municipalities.
METHODS
We identified all women (15-49 years) with a redeemed HC prescription in Finland in 2017 (n = 294,445), and a control group of non-users. Municipal social and health indicators at the population level were retrieved from the nationwide Statistics and Indicator Bank. Differences between the groups across 309 municipalities were calculated, and associations of municipal-specific proportions of HC users with municipal-specific indicators were studied using LASSO (Least Absolute Shrinkage and Selection Operator) models.
RESULTS
Sociodemographic differences between HC users and non-users were non-homogenous across municipalities. Indicators positively associated with HC use included: larger population and higher proportions of population aged 16-24 years, of household-dwelling units with one person, of persons with higher education, and of divorces among those aged 25-64. Lower HC use was associated with higher proportions of Swedish-speaking population, of those aged 7-15 years, of young people not in education/training, and of household-dwelling units in overcrowded conditions. Lower HC use was also associated with indicators of outpatient and inpatient healthcare, and of municipal finances in welfare and healthcare.
CONCLUSIONS
Sociodemographic differences in relation to HC use exist across Finnish municipalities. Municipal indicators of social structure, health and welfare, and investment in and use of healthcare services are related to HC use.
Identifiants
pubmed: 33678190
doi: 10.1186/s12889-021-10512-6
pii: 10.1186/s12889-021-10512-6
pmc: PMC7938490
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
465Subventions
Organisme : Jane ja Aatos Erkon Säätiö
ID : #170062
Organisme : Avohoidon tutkimussäätiö (Foundation for Primary Care Research)
ID : N/A
Références
PLoS One. 2020 Apr 16;15(4):e0231792
pubmed: 32298356
Menopause. 2015 Oct;22(10):1138-46
pubmed: 26125537
Contraception. 2011 Nov;84(5):478-85
pubmed: 22018121
Basic Clin Pharmacol Toxicol. 2010 Feb;106(2):86-94
pubmed: 19961477
BMJ Open. 2018 Dec 18;8(12):e023680
pubmed: 30567823
Contraception. 2009 Dec;80(6):533-9
pubmed: 19913147
Health Rep. 2015 Oct;26(10):21-8
pubmed: 26488824
Acta Obstet Gynecol Scand. 2017 Dec;96(12):1414-1422
pubmed: 28921518
J R Stat Soc Series B Stat Methodol. 2012 Mar;74(2):245-266
pubmed: 25506256
Am J Public Health. 2006 May;96(5):834-9
pubmed: 16571701
Acta Obstet Gynecol Scand. 2017 Jan;96(1):19-28
pubmed: 27861709
Perspect Sex Reprod Health. 2007 Jun;39(2):90-9
pubmed: 17565622
Am J Obstet Gynecol. 2008 May;198(5):e46-7
pubmed: 18313637
BMJ Open. 2020 Oct 15;10(10):e040072
pubmed: 33060091
Inform Health Soc Care. 2018 Sep;43(3):310-319
pubmed: 28388252
Sci Rep. 2020 Jun 4;10(1):9123
pubmed: 32499541
Am J Public Health. 2018 Apr;108(4):538-543
pubmed: 29470111
Obstet Gynecol. 2018 Dec;132(6):1453-1460
pubmed: 30399102
J Biosoc Sci. 2007 Sep;39(5):735-44
pubmed: 17121687